The activation of NFκB and the acute activation of TGF-β1 in human dystrophin-deficient muscle tissue cause the failure of metabolic pathways later in the disease and appear to be associated with symptoms and muscle wasting in DMD [21]. This evidence concerns the gene NFKB1 and Duchenne muscular dystrophy.